About American Oriental Bioengineering Inc.
American Oriental Bioengineering Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China. For more information, visit http://www.bioaobo.com.
Statements made in this press release are forward-looking and are made
pursuant to the safe harbor provisions of the Securities Litigation Reform
Act of 1995. Such statements involve risks and uncertainties that may cause
actual results to differ materially from those set forth in these
statements. The economic, competitive, governmental, technological and
other factors identified in the Company's filings with the Securities and
Exchange Commission, including the Form 10-K for the year ended December
31, 2007, may cause actual results or events to differ materially from
those described in the forward looking statements in this press release.
The Company undertakes no obligation to publicly update or revise any
forward-looking statements, whether because of new information, future
events, or otherwise.
AMERICAN ORIENTAL BIOENGINEERING, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
December 31,
2007 2006
CURRENT ASSETS
Cash and cash equivalents $166,410,075 $87,784,419
Accounts receivable, net 16,494,619 11,141,057
Inventories, net 12,264,536 10,684,316
Advances to suppliers and prepaid
expenses 4,309,352 1,950,101
Notes receivable 2,259,616
'/>"/>
| SOURCE American Oriental Bioengineering, Inc. Copyright©2008 PR Newswire. All rights reserved |